Delphine Lekieffre

Title: Delphine Lekieffre: Innovator in Cancer Treatment

Introduction

Delphine Lekieffre is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on methods to mitigate the side effects of anticancer agents, particularly peripheral neuropathies.

Latest Patents

Delphine holds a patent for a method aimed at preventing peripheral neuropathies induced by anticancer agents. The patent, titled "Method of preventing peripheral neuropathies induced by anticancer agents - Eliprodil, or an enantiomer thereof," indicates that Eliprodil can be administered in combination with anticancer agents to prevent these debilitating side effects. This patent highlights her commitment to improving patient outcomes in cancer therapy. She has 1 patent to her name.

Career Highlights

Delphine Lekieffre is associated with Synthelabo, a company known for its focus on pharmaceutical innovations. Her role at Synthelabo has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research. Her dedication to advancing cancer treatment has positioned her as a key figure in her industry.

Collaborations

Throughout her career, Delphine has worked alongside notable colleagues, including Jesus Benavides and Bernard Scatton. These collaborations have enriched her research and expanded the impact of her innovations in cancer treatment.

Conclusion

Delphine Lekieffre is a trailblazer in the field of cancer treatment, with a focus on reducing the side effects of anticancer therapies. Her innovative patent and work at Synthelabo demonstrate her commitment to improving the lives of patients facing cancer. Her contributions are invaluable to the ongoing fight against this disease.